Biogen Inc. (BIIB) Q3 2026 earnings results
Biogen Inc. (BIIB) reported Q3 2026 results on Oct 28, 2026, 6:07:33 AM ET: adjusted EPS $2.62 vs. $1.99 expected (beat by 31.5%); revenue $2.80B vs. $2.63B expected (beat by 6.6%). Outlook: Full year 2026 Non-GAAP diluted EPS guidance range is $12.20 to $13.00.
| Metric | Reported | Analyst estimate | Result |
|---|---|---|---|
| EPS (adjusted, diluted) | $2.62 | $1.99 | Beat by 31.5% |
| Revenue | $2.80B | $2.63B | Beat by 6.6% |
Analyst estimate: the average forecast before the release.
Source
Figures from the SEC 8-K filing, released Oct 28, 2026, 6:07:33 AM ET. Nexqual published them 32 seconds after release. Each figure is confirmed by two independent extraction methods before it is published.
Year over year
Compared with the same quarter a year earlier (ended September 30, 2025, from the company's SEC filing): revenue grew 10.6% from $2.53B.
Stock reaction
The results came out before the market opened. BIIB closed at $244.05 on October 28, 2026, down 3.4% from its $252.73 close on October 27, 2026 before the results. Latest: $249.65 (close, October 29, 2026), −1.2% since the pre-release close.
Questions and answers
Did Biogen Inc. beat earnings expectations?
Yes. Biogen Inc. reported adjusted EPS of $2.62 against an average analyst estimate of $1.99 (beat by 31.5%), and revenue of $2.80B against $2.63B expected (beat by 6.6%).
What were Biogen Inc.'s Q3 2026 earnings and revenue?
adjusted diluted EPS of $2.62 and revenue of $2.80B. Compared with the same quarter a year earlier (ended September 30, 2025, from the company's SEC filing): revenue grew 10.6% from $2.53B.
When did Biogen Inc. report Q3 2026 earnings?
Oct 28, 2026, 6:07:33 AM ET, in an SEC 8-K filing (Item 2.02).
How did BIIB stock react to the earnings?
The results came out before the market opened. BIIB closed at $244.05 on October 28, 2026, down 3.4% from its $252.73 close on October 27, 2026 before the results. Latest: $249.65 (close, October 29, 2026), −1.2% since the pre-release close.
What did Biogen Inc. say about its outlook?
Full year 2026 Non-GAAP diluted EPS guidance range is $12.20 to $13.00.
More on BIIB
BIIB stock page: price, SEC financials, insider trades, superinvestor holders, analyst estimates and options. All results reported that day: earnings October 28, 2026.
Source: SEC EDGAR 8-K (Item 2.02), Nexqual Earnings Flash. Built October 29, 2026 at 23:07 UTC. Not investment advice.
Data source: Nexqual. Last updated: October 29, 2026 at 23:07 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt